Edition:
United States

Biotechnology & Medical Research

AnaptysBio Inc Says CFO Dominic Piscitelli To Resign, Effective As Of September 9

Aug 19 (Reuters) - AnaptysBio Inc ::ANAPTYSBIO INC - CFO DOMINIC PISCITELLI TO RESIGN, EFFECTIVE AS OF SEPTEMBER 9.ANAPTYSBIO INC - APPOINTED ERIC LOUMEAU AS INTERIM CHIEF FINANCIAL OFFICER AND GENERAL COUNSEL.

4:33pm EDT

Merus Announces Second Quarter Loss Per Share Of Eur 0.51

Aug 19 (Reuters) - Merus NV ::MERUS ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER 2019 AND PROVIDES BUSINESS UPDATE.Q2 LOSS PER SHARE EUR 0.51.Q2 REVENUE EUR 5.6 MILLION VERSUS EUR 6.5 MILLION.Q2 REVENUE ESTIMATE EUR 7.4 MILLION -- REFINITIV IBES DATA.Q2 EARNINGS PER SHARE ESTIMATE EUR -0.48 --...

4:01pm EDT

Mabion Plant In Konstantynow Lodzki Gets Second GMP Certificate

Aug 19 (Reuters) - Mabion SA ::ITS SCIENTIFIC AND INDUSTRIAL MEDICAL BIOTECHNOLOGY PLANT IN KONSTANTYNOW LODZKI GETS GMP CERTIFICATE.SAYS ITS IS SECOND CERTIFICATE RECEIVED AS A RESULT OF INSPECTION COMMISSIONED BY EMA IN PROCESS OF LAUNCHING MABIONCD20 DRUG.

8:51am EDT

Scancell Says Decided to Withdraw IND Application In U.S. To Allow UK Arm OF SCIB1 Trial To Proceed

Aug 19 (Reuters) - Scancell Holdings PLC ::SCANCELL HLDS - UPDATE ON THE SCIB1 PHASE 2 CLINICAL TRIAL.SCANCELL HLDS - UPDATE ON THE SCIB1 PHASE 2 CLINICAL TRIAL.SCANCELL HOLDINGS PLC - CO DECIDED TO WITHDRAW ITS IND APPLICATION IN US TO ALLOW UK ARM OF TRIAL TO PROCEED.SCANCELL HOLDINGS - WILL...

2:00am EDT

Expansion & New Markets

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.